These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 35045696)

  • 1. Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and "booster" dose.
    Attolico I; Tarantini F; Carluccio P; Musto P
    Haematologica; 2022 May; 107(5):1218. PubMed ID: 35045696
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
    Mori Y; Uchida N; Wake A; Miyawaki K; Eto T; Nakamura T; Iwasaki H; Ito Y; Tanimoto K; Katayama Y; Imamura Y; Takahashi T; Fujisaki T; Kamimura T; Choi I; Ishitsuka K; Yoshimoto G; Ogawa R; Sugita J; Takamatsu Y; Tanimoto K; Hidaka T; Miyamoto T; Akashi K; Nagafuji K
    Vaccine; 2023 Nov; 41(47):6899-6903. PubMed ID: 37866994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients.
    Gavriilaki E; Papadopoulou A; Touloumenidou T; Stavridou F; Koravou EE; Giannaki M; Papalexandri A; Karavalakis G; Batsis I; Kourelis A; Chatzopoulou F; Chatzidimitriou D; Sotiropoulos D; Yannaki E; Sakellari I; Anagnostopoulos A
    Bone Marrow Transplant; 2022 Jul; 57(7):1183-1186. PubMed ID: 35449455
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation.
    Mungmunpuntipantip R; Wiwanitkti V
    Transpl Infect Dis; 2022 Jun; 24(3):e13839. PubMed ID: 35419913
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Mamez AC; Pradier A; Giannotti F; Petitpas A; Urdiola MF; Vu DL; Masouridi-Levrat S; Morin S; Dantin C; Clerc-Renaud D; Eberhardt CS; Kaiser L; Simonetta F; Chalandon Y
    Bone Marrow Transplant; 2021 Dec; 56(12):3094-3096. PubMed ID: 34584239
    [No Abstract]   [Full Text] [Related]  

  • 6. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
    Huang A; Cicin-Sain C; Pasin C; Epp S; Audigé A; Müller NJ; Nilsson J; Bankova A; Wolfensberger N; Vilinovszki O; Nair G; Hockl P; Schanz U; Kouyos RD; Hasse B; Zinkernagel AS; Trkola A; Manz MG; Abela IA; Müller AMS
    Transplant Cell Ther; 2022 Apr; 28(4):214.e1-214.e11. PubMed ID: 35092892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
    Easdale S; Shea R; Ellis L; Bazin J; Davis K; Dallas F; Thistlethwayte E; Ethell M; Potter M; Arias C; Anthias C; Nicholson E
    Transplant Cell Ther; 2021 Oct; 27(10):880.e1-880.e4. PubMed ID: 34293520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-COV-2 vaccination after stem cell transplantation for scleroderma.
    Rimar D; Slobodin G; Paz A; Henig I; Zuckerman T
    Ann Rheum Dis; 2021 Oct; 80(10):1354-1355. PubMed ID: 34049853
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.
    Vargas L; Valdivieso N; Tempio F; Simon V; Sauma D; Valenzuela L; Beltrán C; Castillo-Delgado L; Contreras-Benavides X; Acevedo ML; Acevedo J; Gonzalez RI; Valiente-Echeverría F; Soto-Rifo R; Rosemblatt M; Lopez M; Osorio F; Bono MR
    BMC Med; 2022 Jun; 20(1):216. PubMed ID: 35676738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi G; Lippi G
    Clin Chem Lab Med; 2022 May; 60(6):930-933. PubMed ID: 35303764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report.
    Spinner JA; Julien CL; Olayinka L; Dreyer WJ; Bocchini CE; Munoz FM; Devaraj S
    J Heart Lung Transplant; 2022 Feb; 41(2):133-136. PubMed ID: 34911654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination.
    Young JH
    Transplant Cell Ther; 2021 Sep; 27(9):700-701. PubMed ID: 34452720
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.
    Bergamaschi C; Pagoni M; Rosati M; Angel M; Tzannou I; Vlachou M; Darmani I; Ullah A; Bear J; Devasundaram S; Burns R; Baltadakis I; Gigantes S; Dimopoulos MA; Pavlakis GN; Terpos E; Felber BK
    Front Immunol; 2022; 13():899972. PubMed ID: 35693807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Pradier A; Mamez AC; Stephan C; Giannotti F; Masouridi-Levrat S; Wang S; Morin S; Neofytos D; Vu DL; Melotti A; Arm I; Eberhardt CS; Tamburini J; Kaiser L; Chalandon Y; Simonetta F
    Ann Oncol; 2022 Dec; 33(12):1333-1335. PubMed ID: 36116692
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.
    Glück V; Grobecker S; Köstler J; Tydykov L; Bertok M; Weidlich T; Gottwald C; Salzberger B; Wagner R; Zeman F; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
    Infection; 2022 Apr; 50(2):439-446. PubMed ID: 34562263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
    Einarsdottir S; Martner A; Nicklasson M; Wiktorin HG; Arabpour M; Törnell A; Vaht K; Waldenström J; Ringlander J; Bergström T; Brune M; Hellstrand K; Ljungman P; Lagging M
    Haematologica; 2022 Jun; 107(6):1479-1482. PubMed ID: 35236057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.